10.1002/anie.201906834
Angewandte Chemie International Edition
COMMUNICATION
To date, we have managed selectivities of 2–2.5:1, but the trivial
separation of the resulting diastereomers, the avoidance of
stoichiometric mercury reagents, and the identical yield to
Shenvi’s multi-step solution makes this an attractive alternative.
Conversion of 8 to 1 by application of Shenvi’s invertive
isocyanation protocol afforded the natural product exactly as
described.14,15 At this stage, we have made over 30 mg of DICA
via this sequence, without any particular efforts to scale up the
chemistry; indeed, all indications to date suggest that significant
quantities of the natural product should be available when
needed.
Our achievement provides
a
reminder that efficient
syntheses need not necessarily rely on the development of new
chemical methods. Indeed, with the wealth of chemical tools
currently at our disposal, strategic advances will continue to be
major contributors to efficiency.
Acknowledgements
Early studies were supported by the National Science
Foundation (CHE-1564340). This work is currently funded by the
National Institutes of Health (AI-138139).
Keywords: terpenoids • antimalarial • Birch reduction • total
While DICA itself has been tested many times, the activities
of its isonitrile-bearing-carbon stereoisomers have not been
reported. The general preference for equatorial methylation of
cyclohexanones renders 16 particularly well suited to making the
unnatural epimer of DICA with both isonitriles equatorial (C20-
epi-DICA, 17, Figure 2). Treatment of 16 with methylmagnesium
chloride was diastereoselective for equatorial methylation, and
further processing afforded 17.20 The potent activity of DICA is
largely retained in its stereoisomer 17, with only a five-fold
decrease in potency toward a drug-resistant (Dd2) strain of
Plasmodium falciparum and a 25-fold decrease against a drug-
sensitive (3D7) strain. This outcome is consistent with the model
put forth by Wright, Tilley and co-workers pertaining to the
antiplasmodial activity of many polycyclic ICTs;21 their modeling
analysis suggests that the C7 equatorial isonitrile correlates with
significant antiplasmodial activity, and that C20 axial substitution
provides a supportive role in slightly improving potency. The
model appears to embrace either electron-poor or alkyl groups
axial at C20, which is further supported by 17’s only modest loss
in activity. Given this outcome, evaluation of the antiplasmodial
activity of the other C7/C20 diastereomers of DICA is
warranted—especially given the pseudo-symmetry of these
compounds—and will be reported in due course.
synthesis • stereocontrol
[1]
[2]
[3]
M. J. Schnermann, R. A. Shenvi, Nat. Prod. Rep. 2015, 32, 543–577.
J. T. Baker, R. J. Wells, J. Am. Chem. Soc. 1976, 98, 4010–4012.
(a) C. K. Angerhofer, J. M. Pezzuto, G. M. König, A. M. Wright, O.
Sticher, J. Nat. Prod. 1992, 55, 1787–1789; (b) G. M König, A. D.
Wright, C. K. Angerhofer, J. Org. Chem. 1996, 61, 3259–3267; For a
review, see: (c) A. D. Wright, G. M. König, C. K. Angerhofer, P.
Greenidge, A. Linden, R. Desqueyroux-Faúndez, J. Nat. Prod. 1996, 59,
710–716.
[4]
[5]
[6]
Kalihinol B: M. E. Daub, J. Prudhomme, K. Le Roch, C. D. Vanderwal, J.
Am. Chem. Soc. 2015, 137, 4912–4915.
Kalihinol analogues: M. E. Daub, J. Prudhomme, C. Ben Mamoun, K. G.
Le Roch, C. D. Vanderwal, ACS Med. Chem. Lett. 2017, 8, 355–360.
DICA: (a) P. C. Roosen, C. D. Vanderwal, Angew. Chem. Int. Ed. 2016,
55, 7180–7183; Angew. Chem. 2016, 128, 7296–7299; (b) Earlier
routes were unsuccessful: P. C. Roosen, C. D. Vanderwal, Org. Lett.
2014, 16, 4368–4371.
[7]
[8]
A. M. White, K. Dao, D. Vrubliauskas, Z. A. Könst, G. K. Pierens, A.
Mándi, K. T. Andrews, T. S. Skinner-Adams, M. E. Clarke, P. Narbutas,
D. C.-M. Sim, K. L. Cheney, T. Kurtán, M. J. Garson, C. D. Vanderwal,
J. Org. Chem. 2017, 82, 13313–13323.
Such substructures played intermediary roles in other ICT syntheses,
most notably in the Wood and Miyaoka groups’ kalihinol work, wherein
they were generated by intramolecular Diels–Alder reactions. See (a) R.
D. White, G. F. Keaney, C. D. Slown, J. L. Wood, Org. Lett. 2004, 6,
1123–1126. (b) H. Miyaoka, H. Shida, N. Yamada, H. Mitome, Y.
Yamada, Tetrahedron Lett. 2002, 43, 2227–2230. (c) H. Miyaoka, Y.
Abe, N. Sekiya, H. Mitome, E. Kawashima, Chem. Commun. 2012, 48,
901–903. (d) H. Miyaoka, Y. Abe, E. Kawashima, Chem. Pharm. Bull.
2012, 60, 1224–1226.
NC
NC
NC
20
CN
17: C20-epi-DICA
1: DICA
IC50 Dd2: 15 nM
IC50 3D7: 2 nM
78 nM
51 nM
[9]
For a review of recurring themes in ICT synthesis strategies, see: M. E.
Daub, P. C. Roosen, C. D. Vanderwal, J. Org. Chem. 2017, 82, 4533–
4541.
Figure 2. The antiplasmodial activity of DICA and C20-epi-DICA
[10] E. J. Corey, P. A. Magriotis, J. Am. Chem. Soc. 1987, 109, 287–288.
[11] H. Miyaoka, Y. Okubo, M. Muroi, H. Mitome, E. Kawashima, Chem. Lett.
2011, 40, 246–247.
In conclusion, we have developed a particularly concise
synthesis of DICA—based on our general strategy—that
features a rapid buildup of much of its carbon scaffold, followed
by efficient introduction of key stereogenic centers by reduction.
We have thereby reduced the problem posed by DICA to a
sequence of ten chemical steps from simple, known starting
materials, obviating all of the unproductive steps that plagued
our previous effort. This synthesis further showcases the power
of the conjugate addition/enolate trapping strategy as a valuable
means of accessing ICT natural products. We have capitalized
on this short, stereoselective synthesis to produce C20-epi-DICA,
which was tested for antiplasmodial activity for the first time, the
results of which support the current working hypothesis on the
activity of polycyclic ICTs.
[12] E. R. Robinson, R. J. Thomson, J. Am. Chem. Soc. 2018, 140, 1956–
1965.
[13] K. A. Fairweather, L. N. A. Mander, Org. Lett. 2006, 8, 3395–3398.
[14] H.-H Lu, S. V. Pronin, Y. Antonova-Koch, S. Meister, E. A. Winzeler, R.
A. Shenvi, J. Am. Chem. Soc. 2016, 138, 7268–7271.
[15] (a) S. V. Pronin, R. A. Shenvi, J. Am. Chem. Soc. 2012, 134, 19604–
19606. (b) S. V. Pronin, C. A. Reiher, R. A. Shenvi, Nature 2013, 501,
195–199.
[16] We use a slightly modified version of the procedure of Razdan and co-
workers to make dehydrocryptone, in which the three-step sequence is
performed with a single purification by distillation of 11: C. Siegel, P. M.
Gordon, D. B. Uliss, G. R. Handrick, H. C. Dalzell, R. K. Razdan, J. Org.
Chem. 1991, 56, 6865–6872. See ref. 6a for details.
[17] The two reactions can also be combined itno a one-pot four-component
coupling process, albeit with diminished yields (ca. 30%).
This article is protected by copyright. All rights reserved.